CLINICAL_TRIALS
trial_result
· 2022-12-20
Clinical Trial Update: Oxytocin Dosage to Decrease Induction Duration [Phase 4]
Summary
Phase 4 trial update evaluating oxytocin dosage to shorten induction duration.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arizona | Conditions: Obesity, Labor, Induced | Phase 4 | Status: COMPLETED | Results posted: 2022-12-20